Allworth Financial
FENC icon

Allworth Financial’s Fennec Pharmaceuticals FENC Stock Holding History

Allworth Financial’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.95K Hold
274
– – ﹤0.01% 4488
2026
Q2 		$2.95K Buy
274
+251
+1,091% +$2.05K ﹤0.01% 4364
2026
Q1 		$142 Buy
+23
New +$178 ﹤0.01% 4967

Other funds holding FENC

ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
Sierra Summit Advisors
Sierra Summit Advisors Incline Village, Nevada $852M AUM 73.11% 1-Year Est. Return
Thompson Siegel & Walmsley
Thompson Siegel & Walmsley Richmond, Virginia $5.37B AUM 3.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Hartford Financial Management
Hartford Financial Management Hartford, Connecticut $448M AUM 24.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Allworth Financial's FENC Position: Q3 2026 in Review

Allworth Financial held its Fennec Pharmaceuticals (FENC) position steady in Q3 2026 at 274 shares worth $2.95K. The position accounts for ﹤0.01% of the portfolio, ranked #4488.

Allworth Financial first reported a position in FENC in Q1 2026 and has held it in 3 quarters since. 34 funds tracked by Wall St. Rank hold FENC as of Q3 2026.

  • Allworth Financial held 274 shares of Fennec Pharmaceuticals worth $2.95K as of Q3 2026.
  • Allworth Financial left its Fennec Pharmaceuticals share count unchanged in Q3 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #4488 holding.
  • Allworth Financial first reported a position in Fennec Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 34 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2026.

Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.